Advertisement
Screener

STREAMEX CORP. (STEX) Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest

1.4 / 5 stars · 17/59 Roast Me

STREAMEX CORP. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest

STREAMEX CORP. (STEX) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$7.80 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.

Discontinued › Expense Statement › Operating Expenses

us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2021-11-15

  • STREAMEX CORP. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2021-09-30 was -$7.80M.
  • STREAMEX CORP. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2021-06-30 was -$8.05M.
  • STREAMEX CORP. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2021-03-31 was -$8.56M.
  • STREAMEX CORP. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2020-12-31 was -$10.93M.
  • STREAMEX CORP. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2020 was -$59.18M.
Period endIncome (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 monthIncome (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filedIncome (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 monthIncome (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month as first filedIncome (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 monthIncome (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month as first filedIncome (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month
2021-09-30-$7.80M
10-Q · filed 2021-11-15
-$15.85M
derived: sum of 2 quarters · filed 2021-11-15
-$24.41M
10-Q · filed 2021-11-15
-$35.34M
derived: sum of 4 quarters · filed 2021-11-15
2021-06-30-$8.05M
10-Q · filed 2021-08-11
-$16.61M
10-Q · filed 2021-08-11
-$27.54M
derived: sum of 3 quarters · filed 2021-08-11
-$40.64M
derived: sum of 4 quarters · filed 2021-11-15
2021-03-31-$8.56M
10-Q · filed 2021-05-17
-$19.49M
derived: sum of 2 quarters · filed 2021-05-17
-$32.59M
derived: sum of 3 quarters · filed 2021-11-15
-$54.94M
derived: sum of 4 quarters · filed 2021-11-15
2020-12-31-$10.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15
-$24.03M
derived: sum of 2 quarters · filed 2021-11-15
-$46.38M
derived: sum of 3 quarters · filed 2021-11-15
-$59.18M
10-K · filed 2021-03-15
2020-09-30-$13.10M
10-Q · filed 2021-11-15
-$13.10M
10-Q · filed 2020-11-05
-$35.45M
derived: sum of 2 quarters · filed 2021-11-15
-$48.25M
10-Q · filed 2021-11-15
-$48.25M
10-Q · filed 2020-11-05
2020-06-30-$22.35M
10-Q · filed 2021-08-11
-$22.35M
10-Q · filed 2020-08-06
-$35.15M
10-Q · filed 2021-08-11
-$35.15M
10-Q · filed 2020-08-06
2020-03-31-$12.80M
10-Q · filed 2021-05-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nexalin Technology, Inc. (NXL)United States$0.094B
Neuraxis, INC (NRXS)United States$0.097B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
IRIDEX CORP (IRIX)United States$0.011B
ENDRA Life Sciences Inc. (NDRA)United States$0.009B